Back to BlackRock, Inc. BlackRock, Inc.

SPRYSPRY
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ARS PHARMACEUTICALS INC

BlackRock, Inc. holds 5.3M shares of SPRY (ARS PHARMACEUTICALS INC), worth $42.5M as of 2026-Q2. The position was increased (+6.0% shares). SPRY represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$42.5M

Current Shares

5.3M

Total Value Change

-$5.7M

Total Shares Change

+736,828

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.3M
+6.0%
$42.5M0.0%$8.01
31
2026-Q1
Decreased
5M
-1.4%
$40.2M0.0%$8.87
0
2025-Q4
Increased
5.1M
+5.3%
$59.2M0.0%$11.64
31
2025-Q3
Increased
4.8M
+9.2%
$48.6M0.0%$9.72
32
2025-Q2
Increased
4.4M
+2.9%
$77.2M0.0%$18.20
31
2025-Q1
Decreased
4.3M
-6.0%
$54.1M0.0%$12.49
0
2024-Q4
New
4.6M
-
$48.3M0.0%$10.62
40

Other major holders of SPRY: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used